Outcomes4Me
Sucher für klinische Onkologie-Studien
Brustkrebs
Ort

RECRUITING • Phasen O • Stufe 0, I, II, III, IV • Post-Menopausal • Interventionell

Folgendes wird aus ClinicalTrials.gov importiert:

3D Ultrasound for the Imaging of Lymph Nodes in Patients with Breast Cancer

This early phase I studies how well a new 3D ultrasound (3D-US) imaging technology works in evaluating lymph nodes in patients with breast cancer. Ultrasound uses high-frequency sound waves to generate images of the body.

PRIMARY OBJECTIVES: I. Conducting a pilot study to optimize the in vivo performance of the newly developed three-dimensional (3D)-ultrasound (US) technology. II. Evaluate the performance of the new 3D-US technique in differentiating benign from malignant lymph nodes in patients. III. Compare the performance of the new 3D-US method with conventional two-dimensional (2D)-US for localizing the clipped lymph nodes. OUTLINE: Patients undergo 3D-US on study. Patients who have a lymph node clip placed and undergoing neoadjuvant chemotherapy undergo imaging of the clipped node before surgery.

Breast Cancer

Studiendesign
Studientyp:

INTERVENTIONAL

Geschätzte Einschreibung:

80 Teilnehmer

Aktueller Studienbeginn:

14. Februar 2023

Zulassungskriterien
Alter für die Studie berechtigt:

18 - 999

Geschlechter für die Studie berechtigt:

female


Arms and Intervention
  • Ultrasound Imaging

Einschlusskriterien
  • * patients with lymph node biopsy or lymph node clip placement as per routine clinical care.

  • * age of 18 or older.

Ausschlusskriterien
  • * vulnerable subjects such as prisoners and adults lacking capacity to consent.

Trial Information at Site
Last Updated:
Studieninformationen
ClinicalTrial.gov ID:

RECRUITING

Estimated Enrollment:

80

Last Updated:

03/28/2025


Kontakt vor Ort

Clinical Trials Referral Office

mayocliniccancerstudies@mayo.edu

855-776-0015

Mayo Clinic in Rochester

Rochester, Minnesota, United States, 55905


Trial Contact

Clinical Trials Referral Office

mayocliniccancerstudies@mayo.edu

855-776-0015


Hauptermittler

Shigao D Chen, PhD


Studiensponsor

Mayo Clinic

Study Location (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Outcomes4Me

© 2025 Outcomes4Me Inc. All rights reserved.